Yasmin is a combined oral contraceptive pill that offers dual-action benefits for women seeking effective birth control and improved skin health. Each tablet contains a balanced formulation of ethinylestradiol and drospirenone, providing 24-hour contraceptive coverage while also addressing moderate acne vulgaris in women who choose oral contraception. This product is designed for daily administration as part of a structured 28-day cycle, offering both convenience and clinical efficacy when used as directed under medical supervision.

Features

• Contains 0.03 mg ethinylestradiol and 3 mg drospirenone per active tablet
• 21 active hormone tablets + 7 placebo tablets per blister pack
• Monophasic formulation with consistent hormone levels throughout cycle
• Anti-mineralocorticoid activity reduces water retention
• Anti-androgenic properties help manage acne and hirsutism
• 24-hour contraceptive coverage with once-daily dosing
• Calendar-based blister pack for ease of use
• Temperature-stable formulation requiring no refrigeration

Benefits

• Provides highly effective pregnancy prevention when taken correctly (99% efficacy)
• Reduces occurrence of moderate acne lesions through anti-androgenic action
• Demonstrates favorable cycle control with predictable withdrawal bleeding
• May alleviate symptoms of premenstrual syndrome and water retention
• Offers non-contraceptive health benefits including reduced ovarian cancer risk
• Provides reversible contraception that quickly returns to fertility after discontinuation

Common use

Yasmin is primarily prescribed for contraception in women of reproductive age. Additionally, it is indicated for the treatment of moderate acne vulgaris in women at least 14 years old who have no known contraindications to combined hormonal contraception, have achieved menarche, and desire oral contraception. The acne treatment benefit is achieved through drospirenone’s anti-androgenic activity, which reduces sebum production and improves skin condition over successive treatment cycles.

Dosage and direction

Take one tablet daily at approximately the same time each day, following the directional arrows on the blister pack. Begin with the first active tablet (marked with day of week) on the first day of menstrual bleeding or the Sunday after menstruation begins. Continue taking one tablet daily for 21 consecutive days, followed by 7 days of placebo tablets. Withdrawal bleeding typically occurs during the placebo week. Start a new pack the day after finishing the previous pack, regardless of bleeding status. For first-cycle protection, use additional contraception for the first 7 days of administration.

Precautions

Medical examination should precede prescription, including blood pressure measurement and assessment of personal and family medical history. Regular follow-up visits are recommended at least every 6 months. Discontinue immediately if any of the following occur: sudden severe headache, migraine with aura, sudden partial or complete loss of vision, thrombosis symptoms, chest pain, unexplained breathlessness, jaundice, hepatitis, significant blood pressure increase, or severe abdominal pain. Smoking increases risk of serious cardiovascular side effects, particularly in women over 35 years.

Contraindications

• Thrombosis or thromboembolic disorders currently or in history
• Known or suspected carcinoma of breast or estrogen-dependent neoplasia
• Undiagnosed abnormal genital bleeding
• Known or suspected pregnancy
• Liver tumors, active liver disease, or severe hepatic impairment
• Hypersensitivity to any component of Yasmin
• Major surgery with prolonged immobilization
• Diabetes with vascular complications
• Severe hypertension
• Migraine with aura at any age
• Current or history of pancreatitis with hypertriglyceridemia

Possible side effects

Common side effects (may affect up to 1 in 10 users): headache, nausea, breast tenderness, mood changes, menstrual cycle irregularities during initial cycles. Less common side effects (may affect up to 1 in 100 users): vomiting, diarrhea, contact lens intolerance, weight changes, hypertension, libido changes. Rare but serious side effects requiring immediate medical attention: venous thromboembolism, arterial thromboembolism, hepatic tumors, gallbladder disease, hypertension, and rare cases of hormone-dependent cancers.

Drug interaction

Yasmin’s efficacy may be reduced by: antibiotics (particularly rifampicin), anticonvulsants (carbamazepine, phenytoin, barbiturates), antiretroviral medications, St. John’s Wort, and some antifungal agents. Drospirenone may increase potassium levels when taken with other potassium-sparing drugs, ACE inhibitors, angiotensin-II receptor antagonists, heparin, aldosterone antagonists, and NSAIDs. Consult healthcare provider about all medications, including over-the-counter products and herbal supplements.

Missed dose

If less than 12 hours late: take tablet immediately and continue schedule. If more than 12 hours late: take missed tablet immediately, even if two tablets in one day, and use additional contraception for next 7 days. If missed during first week and had intercourse in previous 5 days, consider emergency contraception. If three or more active tablets missed: discard current pack, start new pack after 7-day tablet-free interval, and use additional contraception for 7 days.

Overdose

Serious ill effects have not been reported following overdose. Possible symptoms may include nausea, vomiting, and withdrawal bleeding. There is no specific antidote. Treatment should be symptomatic. Medical supervision is recommended, particularly for children who might accidentally ingest tablets.

Storage

Store at room temperature (15-30°C) in original blister pack to protect from light and moisture. Keep out of reach of children. Do not use after expiration date printed on packaging. Do not transfer tablets to other containers, as this may affect stability and identification.

Disclaimer

This information does not replace professional medical advice. Yasmin is available by prescription only after thorough medical evaluation. The prescribing physician should assess individual risk factors and contraindications before initiation. Patients should read the package leaflet thoroughly and discuss any concerns with their healthcare provider. Efficacy rates refer to perfect use; typical use efficacy is approximately 91%.

Reviews

Clinical studies demonstrate high user satisfaction with Yasmin, particularly regarding cycle regularity and acne improvement. In a 12-month study of 1,200 women, 88% reported improved or much improved acne symptoms by cycle 6. Satisfaction with contraceptive reliability was reported at 94% among perfect users. Some users note initial adjustment symptoms including mild nausea and breast tenderness, which typically resolve within the first three cycles. Healthcare providers report good tolerability and adherence with the 24/4 dosing regimen.